TrialFrontiers in immunology2023

Intralymphatic glutamic acid decarboxylase administration in type 1 diabetes patients induced a distinctive early immune response in patients with DR3DQ2 haplotype.

Sara Puente-Marin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.